Role of Peroxisome Proliferator-Activated Receptor-γ and Its Coactivator DRIP 205 in Cellular Responses to CDDO ( RTA-401 ) in Acute Myelogenous Leukemia
暂无分享,去创建一个
K. Coombes | Z. Ju | M. Konopleva | M. Andreeff | H. Kantarjian | D. Kardassis | M. Abdelrahim | S. Kornblau | V. Ruvolo | T. Tsao | Y. Qiu | Wenjing Chen | W. Schober | A. Schimmer | Xiaoyang Ling | C. Meyer | S. Safe | J. Watt
[1] M. Sporn,et al. Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription , 2009, PloS one.
[2] F. Khuri,et al. Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation. , 2008, Cancer research.
[3] J. Issa,et al. PPARgamma-Active triterpenoid CDDO enhances ATRA-induced differentiation in APL , 2007, Cancer biology & therapy.
[4] R. Roeder,et al. Alternative Mechanisms by Which Mediator Subunit MED1/TRAP220 Regulates Peroxisome Proliferator-Activated Receptor γ-Stimulated Adipogenesis and Target Gene Expression , 2007, Molecular and Cellular Biology.
[5] M. Sporn,et al. CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha. , 2007, Blood.
[6] J. Milbrandt,et al. Abrogation of nuclear receptors Nr4a3 andNr4a1 leads to development of acute myeloid leukemia , 2007, Nature Medicine.
[7] M. Sporn,et al. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer , 2007, Nature Reviews Cancer.
[8] N. Hawker,et al. Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3. , 2007, The Journal of investigative dermatology.
[9] N. Hawker,et al. Differential role of two VDR coactivators, DRIP205 and SRC-3, in keratinocyte proliferation and differentiation , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[10] M. Konopleva,et al. The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore. , 2007, Cancer research.
[11] P. Nowell,et al. Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene , 2007, Cancer biology & therapy.
[12] Patrick Rodriguez,et al. The mediator complex functions as a coactivator for GATA-1 in erythropoiesis via subunit Med1/TRAP220 , 2006, Proceedings of the National Academy of Sciences.
[13] G. Mills,et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells , 2006, Molecular Cancer Therapeutics.
[14] M. Sporn,et al. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells , 2006, Molecular Cancer Therapeutics.
[15] M. Sporn,et al. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. , 2006, Cancer research.
[16] M. Konopleva,et al. Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells , 2006, Molecular Cancer Therapeutics.
[17] M. Konopleva,et al. A Novel Mechanism of Action of Methyl-2-cyano-3,12 Dioxoolean-1,9 Diene-28-oate: Direct Permeabilization of the Inner Mitochondrial Membrane to Inhibit Electron Transport and Induce Apoptosis , 2005, Molecular Pharmacology.
[18] R. Roeder,et al. The role of transcriptional coactivator TRAP220 in myelomonocytic differentiation , 2005, Genes to cells : devoted to molecular & cellular mechanisms.
[19] M. Sporn,et al. 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) Directly Targets Mitochondrial Glutathione to Induce Apoptosis in Pancreatic Cancer* , 2005, Journal of Biological Chemistry.
[20] M. Konopleva,et al. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid and Related Compounds Inhibit Growth of Colon Cancer Cells through Peroxisome Proliferator-Activated Receptor γ-Dependent and -Independent Pathways , 2005, Molecular Pharmacology.
[21] Paul Talalay,et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Safe,et al. Vitamin D-interacting Protein 205 (DRIP205) Coactivation of Estrogen Receptor α (ERα) Involves Multiple Domains of Both Proteins* , 2004, Journal of Biological Chemistry.
[23] J. Hong,et al. Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins. , 2004, Endocrinology.
[24] M. Sporn,et al. The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-Dependent and -Independent Apoptosis in Acute Myelogenous Leukemia , 2004, Cancer Research.
[25] M. Sporn,et al. c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells , 2004, Cancer Research.
[26] M. Konopleva,et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. , 2004, Molecular cancer therapeutics.
[27] S. Safe,et al. A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes , 2004, Molecular Cancer Therapeutics.
[28] M. Sporn,et al. Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL , 2003, Leukemia.
[29] D. Gold,et al. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. , 2003, Cancer research.
[30] O. Coqueret,et al. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? , 2003, Trends in cell biology.
[31] A. Moustakas,et al. The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF-1/Cip1 gene promoter. , 2002, Biochemistry.
[32] M. Sporn,et al. The triterpenoid CDDO induces apoptosis in refractory CLL B cells. , 2002, Blood.
[33] M. Konopleva,et al. Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies. , 2002, Current opinion in hematology.
[34] M. Sporn,et al. Chemoprevention: an essential approach to controlling cancer , 2002, Nature Reviews Cancer.
[35] Yang Li,et al. T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities* , 2002, The Journal of Biological Chemistry.
[36] M. Sporn,et al. The Novel Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) Potently Enhances Apoptosis Induced by Tumor Necrosis Factor in Human Leukemia Cells* , 2002, The Journal of Biological Chemistry.
[37] Tadashi Honda,et al. Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. , 2002, Blood.
[38] E. Estey,et al. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. , 2001, The Journal of clinical investigation.
[39] L. Freedman,et al. Discrete Roles for Peroxisome Proliferator-Activated Receptor γ and Retinoid X Receptor in Recruiting Nuclear Receptor Coactivators , 2000, Molecular and Cellular Biology.
[40] M. Sporn,et al. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma. , 2000, Molecular endocrinology.
[41] L. Freedman,et al. Functional Interactions between the Estrogen Receptor and DRIP205, a Subunit of the Heteromeric DRIP Coactivator Complex* , 2000, The Journal of Biological Chemistry.
[42] M. Sporn,et al. The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[43] M. Lazar,et al. The DRIP Complex and SRC-1/p160 Coactivators Share Similar Nuclear Receptor Binding Determinants but Constitute Functionally Distinct Complexes , 2000, Molecular and Cellular Biology.
[44] R. Espinosa,et al. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[45] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[46] M. Sporn,et al. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. , 1999, Cancer research.
[47] J. Auwerx,et al. The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene* , 1997, The Journal of Biological Chemistry.